154
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Efficacy of methylergometrine during the early puerperium: a randomized double-blind placebo-controlled clinical trial

, , , ORCID Icon, &
Pages 1744-1748 | Received 10 Apr 2018, Accepted 25 Sep 2018, Published online: 29 Oct 2018

References

  • Prendiville WJ, Elbourne D, McDonald SJ. Active versus expectant management in the third stage of labour. Cochrane Database Syst Rev. 2000;3:CD000007.
  • Arabin B, Rüttgers H, Kubli F. Effects of routine administration of methylergometrin during puerperium on involution, maternal morbidity and lactation. Geburtshilfe Frauenheilkd. 1986;46(4):215–220.
  • Borri P, Gerli P, Antignani FL, et al. Methylergonovine maleate: a proposal for its more specific use. Biol Res Pregnancy Perinatol. 1986;7(3):128–130.
  • Klug PW, Mayer HG. Effect of methylergometrin on involution of the uterus in the early puerperium. Z Geburtshilfe Perinatol. 1983;187(4):203–204.
  • Iatrakis GM, Sakellaropoulos GG, Kourounis G, et al. Methylergometrine and puerperal infections after normal delivery and after cesarean section. Isr J Med Sci. 1989;25(12):714–715.
  • Andersen B, Andersen LL, Sørensen T. Methylergometrine during the early puerperium; a prospective randomized double blind study. Acta Obstet Gynecol Scand. 1998;77(1):54–57.
  • Yaju Y, Kataoka Y, Eto H, et al. Prophylactic interventions after delivery of placenta for reducing bleeding during the postnatal period. Cochrane Database Syst Rev. 2013;26(11):CD009328.
  • Bateman BT, Huybrechts KF, Hernandez-Diaz S, et al. Methylergonovine maleate and the risk of myocardial ischemia and infarction. Am J Obstet Gynecol. 2013;209(5):459.e1–459.e13.
  • de Groot AN, van Dongen PW, Vree TB, et al. Ergot alkaloids. Current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology. Drugs. 1998;56(4):523–535.
  • de Labriolle A, Genée O, Heggs LM, et al. Acute myocardial infarction following oral methyl-ergometrine intake. Cardiovasc Toxicol. 2009;9(1):46–48.
  • Westhoff G, Cotter AM, Tolosa JE. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. Cochrane Database Syst Rev. 2013;10(10):CD001808.
  • Hofmeyr GJ, Mshweshwe NT, Gülmezoglu AM. Controlled cord traction for the third stage of labour. Cochrane Database Syst Rev. 2015;1:CD008020.
  • Saccone G, Caissutti C, Ciardulli A, et al. Uterine massage as part of active management of the third stage of labour for preventing postpartum haemorrhage during vaginal delivery: a systematic review and meta-analysis of randomised trials. BJOG. 2018;125(7):778–781.
  • Saccone G, Ciardulli A, Baxter JK, et al. Discontinuing oxytocin infusion in the active phase of labor: a systematic review and meta-analysis. Obstet Gynecol. 2017;130(5):1090–1096.
  • Weber S, Cabanes L, Simon JC, et al. Systemic alkalosis as a provocative test for coronary artery spasm in patients with infrequent resting chest pain. Am Heart J. 1988;115(1 Pt 1):54–59.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.